Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06996106

Outcomes of PRF on Septoplasty in Patient With Nasal Septal Deviation

Effect of Platelet Rich Fibrin on Septoplasty :A Comparative Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Kafrelsheikh University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to assess the effectiveness of Platelet-Rich Fibrin (PRF) in improving postoperative healing, reducing complications, and enhancing functional outcomes in patients undergoing septoplasty

Detailed description

Septoplasty is a routine surgical intervention to correct nasal septal deviation, a major cause of nasal obstruction and chronic sinusitis. Despite advancements, postoperative complications-such as mucosal injury, synechiae, septal perforation, and hematoma-continue to impact outcomes and patient satisfaction. Platelet-rich fibrin (PRF), first described by Choukroun et al., represents an autologous biomaterial rich in growth factors like PDGF, TGF-β, VEGF, and IGF-1, known to accelerate wound healing and tissue regeneration. Unlike platelet-rich plasma (PRP), PRF is easier to prepare, does not require anticoagulants, and forms a fibrin matrix conducive to sustained release of cytokines. Several studies across disciplines-oral surgery, dermatology, orthopedics-support the regenerative potential of PRF. In nasal surgery, the delicate mucosal environment could benefit significantly from enhanced healing facilitated by PRF.

Conditions

Interventions

TypeNameDescription
OTHEREffect of Platelet Rich Fibrin on Septoplastyit is a randomized trial of usage of platelet rich fibrin in septoplasty

Timeline

Start date
2025-06-01
Primary completion
2026-01-01
Completion
2026-02-01
First posted
2025-05-30
Last updated
2025-05-30

Source: ClinicalTrials.gov record NCT06996106. Inclusion in this directory is not an endorsement.